US5213788A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
Assignee: Abeona Therapeutics Inc
•
Filing: 1991-04-04
•
Granted: 1993-05-25
•
Expires: 2011-04-04
Abstract
Abstract Improved compositions and methods for selective access to tumor regions (or other regions of abnormal endothelial properties). This capability provides powerful contrast-enhancement agents for nuclear magnetic resonance imaging. A polyatomic complex which includes intramolecular ferromagnetic coupling between metal atoms is associated with a polymer or microsphere carrier matrix which will bind to endothelial determinants. A solution containing this carrier complex is injected into a human (or other) body to be imaged. The carrier complex will preferentially extravasate at locations where the blood vessel walls have increased porosity or microvascular surface changes, and especially at tumor sites. Thus, the changes in relaxation time induced by the presence of the carrier complex will provide a high-gain marker for magnetic resonance imaging. Multiple superparamagnetic polyatomic complexes are described, including novel complexes which include acetate and glycinate bridging ligands with a polyatomic metal-atom-complex core.
Inventors
- 👤 David F. Ranney
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 07:52
CPC Classifications
G; G01; G01R; G01R33/00; G01R33/20; G01R33/44; G01R33/48; G01R33/54; G01R33/56; G01R33/5601; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/61; A61K49/00; A61K49/06; A61K49/08; A61K49/085; A61K49/10; A61K49/12; A61K49/126; A61K49/128; A61K49/18; A61K49/1818; A61K49/1821; A61K49/1824; A61K49/1827; A61K49/1833; A61K49/1836; A61K49/1845; A61K49/1851; A61K49/1863; Y; Y10; Y10S; Y10S436/00; Y10S436/806; Y10T; Y10T436/00; Y10T436/24
Claims Analysis
Total Claims: 45
Claim 1
Independent Claim
186 words
A composition of matter for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising: a polyatomic complex comprising plural atoms having magnetic moments which are mutually magnetically coupled within the polyatomic complex, said complex including bridging molecular or atomic species which are individually bound to at least one of said plural atoms having magnetic moments and other atoms of the polyatomic complex, said polyatomic complex essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, said bridging molecular species being free of intermolecular bonds; and a biocompatible, physiologically clearable carrier associated with the polyatomic complex, said carrier comprising heparin having a molecular weight between about 6,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia, said carrier being in association with said polyatomic complex; wherein the proportion of said polyatomic complex to said carrier is at least about 1:20 by weight; said carrier being of low toxicity to mammals and containing less than about 5 weight percent cross-linked or microaggregated species.
Claim 2
Dependent Claim
186 words
A composition of matter for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising: a polyatomic complex comprising plural atoms having magnetic moments which are mutually magnetically coupled within the polyatomic complex, said complex including bridging molecular or atomic species which are individually bound to at least one of said plural atoms having magnetic moments and other atoms of the polyatomic complex, said polyatomic complex essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, said bridging molecular species being free of intermolecular bonds; and a biocompatible, physiologically clearable carrier associated with the polyatomic complex, said carrier comprising heparin having a molecular weight between about 6,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia, said carrier being in association with said polyatomic complex; wherein the proportion of said polyatomic complex to said carrier is at least about 1:20 by weight; said carrier being of low toxicity to mammals and containing less than about 5 weight percent cross-linked or microaggregated species.
Claim 3
Dependent Claim
11 words
The composition of claim 1, wherein the heparin is beef-lung heparin.
Claim 4
Dependent Claim
12 words
The composition of claim 1, wherein the heparin is Fraction A heparin.
Claim 5
Dependent Claim
16 words
The composition of claim 1, wherein the heparin has a mean molecular weight of about 8,000.
Claim 6
Dependent Claim
191 words
A composition of matter for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising: a polyatomic complex comprising plural atoms having magnetic moments which are mutually magnetically coupled within the polyatomic complex, said complex including bridging molecular or atomic species which are individually bound to at least one of said plural atoms having magnetic moments and other atoms of the polyatomic complex, said polyatomic complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, said bridging molecular species being free of intermolecular bonds; and a biocompatible, physiologically clearable carrier associated with the polyatomic complex, said carrier comprising Fraction A of beef-lung heparin having a molecular weight between about 6,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia; said carrier being in association with said polyatomic complex; wherein the proportion of said polyatomic complex to said carrier is at least about 1:20 by weight; said carrier being of low toxicity to mammals and containing less than about 5 weight percent cross-linked or microaggregated species.
Claim 7
Dependent Claim
191 words
A composition of matter for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising: a polyatomic complex comprising plural atoms having magnetic moments which are mutually magnetically coupled within the polyatomic complex, said complex including bridging molecular or atomic species which are individually bound to at least one of said plural atoms having magnetic moments and other atoms of the polyatomic complex, said polyatomic complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, said bridging molecular species being free of intermolecular bonds; and a biocompatible, physiologically clearable carrier associated with the polyatomic complex, said carrier comprising Fraction A of beef-lung heparin having a molecular weight between about 6,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia; said carrier being in association with said polyatomic complex; wherein the proportion of said polyatomic complex to said carrier is at least about 1:20 by weight; said carrier being of low toxicity to mammals and containing less than about 5 weight percent cross-linked or microaggregated species.
Claim 8
Dependent Claim
196 words
A composition of matter for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising: a polyatomic complex comprising plural atoms having magnetic moments which are mutually magnetically coupled within the polyatomic complex, said complex including bridging molecular or atomic species which are individually bound to at least one of said plural atoms having magnetic moments and other atoms of the polyatomic complex, said polyatomic complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, said bridging molecular species being free of intermolecular bonds; and a biocompatible, physiologically clearable carrier associated with the polyatomic complex, said carrier comprising Fraction A heparin or a fragment thereof having a molecular weight between about 1,000 Daltons and about 10,000 Daltons, and having binding complementarity to determinants of mammlian endothelia and epithelia; said carrier substance being in association with said polyatomic complex; wherein the proportion of said polyatomic complex to said carrier is at least about 1:20 by weight and said carrier contains less than about 5 weight percent cross-linked or microaggregated species and being of low toxicity to mammals.
Claim 9
Dependent Claim
196 words
A composition of matter for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising: a polyatomic complex comprising plural atoms having magnetic moments which are mutually magnetically coupled within the polyatomic complex, said complex including bridging molecular or atomic species which are individually bound to at least one of said plural atoms having magnetic moments and other atoms of the polyatomic complex, said polyatomic complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, said bridging molecular species being free of intermolecular bonds; and a biocompatible, physiologically clearable carrier associated with the polyatomic complex, said carrier comprising Fraction A heparin or a fragment thereof having a molecular weight between about 1,000 Daltons and about 10,000 Daltons, and having binding complementarity to determinants of mammlian endothelia and epithelia; said carrier substance being in association with said polyatomic complex; wherein the proportion of said polyatomic complex to said carrier is at least about 1:20 by weight and said carrier contains less than about 5 weight percent cross-linked or microaggregated species and being of low toxicity to mammals.
Claim 10
Dependent Claim
14 words
The composition of claim 1 wherein the carrier is in association by covalent bonding.
Claim 11
Dependent Claim
12 words
The composition of claim 1 wherein the heparin is native or modified.
Claim 12
Dependent Claim
29 words
The composition of claim 1 wherein said plural atoms include at least one of: chromium, copper, manganese, iron, platinum, cobalt, vanadium, molybdenum, tungsten, gadolinium, erbium dysprosium, europium and holmium.
Claim 13
Dependent Claim
75 words
The composition of claim 1 wherein said polyatomic complex has the formula (Cr 4 SR n X m ), where R is a molecular species which is at least one of formate, formaldehyde, glutaraldehyde, acetate, glycinate, succinate, acetylacetonate, malonate, propionate, glutarate, hydroxamate, oxalate, 2-bromacetate, 2-sulfoethanoate, thiolacetate and thioglycolate; n is between 4 and 12; X is at least one of halide, sulfate, nitrate, carboxylate and phosphate stabilizing counterions; and m is between 1 and 2n.
Claim 14
Dependent Claim
14 words
The composition of claim 1 wherein the plural atoms having magnetic moments comprise Cr(III).
Claim 15
Dependent Claim
27 words
The composition of claim 1 wherein the polymeric complex comprises four Cr(III) atoms bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging species.
Claim 16
Dependent Claim
24 words
The composition of claim 1, wherein said polyatomic complex comprises Cr 4 S(O 2 CCH 3 ) 8 (H 2 O) 4 +2 .
Claim 17
Dependent Claim
23 words
The composition of claim 1 wherein said polyatomic complex is associated with said carrier noncovalently through a strong ionic, paired-ion, or charge interaction.
Claim 18
Dependent Claim
46 words
The composition of claim 14 wherein said strong interaction involves chemical coordination or chelation binding of said polyatomic complex to at least one reactive group of said carrier, each reactive group on said carrier, having a coordination number or ionic charge number between 2 and 10.
Claim 19
Dependent Claim
15 words
The composition of claim 1 wherein said polyatomic complex is covalently associated with said carrier.
Claim 20
Dependent Claim
15 words
The composition of claim 1 wherein said association is stabilized by physical or chemical means.
Claim 21
Dependent Claim
31 words
The composition of claim 17, wherein said association is stabilized by heating of a pre-dried polyatomic complex plus carrier combination to at least about 100 degrees Celsius in an organic solvent.
Claim 22
Dependent Claim
11 words
The composition of claim 18 wherein the organic solvent is acetone.
Claim 23
Dependent Claim
14 words
The composition of claim 18 wherein the organic solvent comprises a detergent or surfactant.
Claim 24
Dependent Claim
21 words
The composition of claim 18 wherein the organic solvent comprises between about 0.01% and about 25% detergent or surfactant by weight.
Claim 25
Dependent Claim
13 words
The composition of claim 18 wherein the organic solvent comprises a biocompatible oil.
Claim 26
Dependent Claim
12 words
The composition of claim 18 wherein the organic solvent comprises a polyol.
Claim 27
Dependent Claim
11 words
The composition of claim 23 wherein the polyol is polyethylene glycol.
Claim 28
Dependent Claim
10 words
The composition of claim 23 wherein the polyol is glycerol.
Claim 29
Dependent Claim
53 words
The composition of claim 17, wherein said association is stabilized by heating a pre-dried polyatomic complex and carrier combination to at least about 100 degrees Celsius in acetone, acetone comprising a polyosyethylene sorbitan mono-oleate detergent at between about 0.01 weight % and about 25 weight %, polyethylene glycol, glycerol or a biocompatible oil.
Claim 30
Dependent Claim
29 words
The composition of claim 1 wherein said polyatomic complex and said carrier are further formulated to produce nanoparticles between about 5 nanometers and about 99 nanometers in mean diameter.
Claim 31
Dependent Claim
29 words
The composition of claim 27 wherein said polyatomic complex is Cr 4 S(O 2 CCH 3 ) 8 (H 2 O) n , where n is 1 to 4.
Claim 32
Dependent Claim
59 words
The composition of claim 5 wherein said polyatomic complex and carrier are further formulated to produce microparticles having a mean diameter between about 0.1 micrometers and about 15 micrometers, and said polyatomic complex is in association with a carrier comprising at least one of protamine, hexadimethrine, starch, and dextran, the heparin being at least a portion of microparticle surface.
Claim 33
Dependent Claim
29 words
The composition of claim 29 wherein said polyatomic complex is Cr 4 S(O 2 CCH 3 ) 8 (H 2 O) n , where n is 1 to 4.
Claim 34
Dependent Claim
51 words
The composition of claim 1 wherein said polyatomic complex comprises Cr 4 S(O 2 CCH 3 ) 8 (H 2 O) n , where n is between 1 and 4, and said carrier includes at least one of a dicarboxymethyl conjugate, succinate conjugate, ethylenediaminetetraacetate conjugate or diethylenetriaminepentaacetate conjugate of said heparin.
Claim 35
Dependent Claim
115 words
A composition of matter comprising a metal atom complex, said polyatomic complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, bound by chelation, coordination or multiply paired-ion strong association to a biocompatible, clearable carrier comprising native or modified Fraction A of beef-lung heparin having a molecular weight between about 1,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia; wherein said polyatomic complex and said carrier are in a weight ratio of at least about 1:20; and said carrier is nontoxic to mammals and contains less than about 5 weight percent cross-linked or microaggregated species.
Claim 36
Dependent Claim
115 words
A composition of matter comprising a metal atom complex, said polyatomic complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, bound by chelation, coordination or multiply paired-ion strong association to a biocompatible, clearable carrier comprising native or modified Fraction A of beef-lung heparin having a molecular weight between about 1,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia; wherein said polyatomic complex and said carrier are in a weight ratio of at least about 1:20; and said carrier is nontoxic to mammals and contains less than about 5 weight percent cross-linked or microaggregated species.
Claim 37
Independent Claim
240 words
A method for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising the steps of: identifying a living vertebrate animal to be imaged; introducing into the blood stream or body cavity of said animal a diagnostic imaging or enhancing agent or spectral shift agent comprising a substantially completely water-soluble polymeric carrier molecule of native or modified Fraction A heparin or fragment thereof having a molecular weight range between about 1,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia, said agent also comprising a polyatomic complex associated with said carrier molecule, said polyatomic complex including plural atoms of magnetic moment which are mutually magnetically coupled within the polyatomic complex said polyatomic complex essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, applying to said animal a strong magnetic field which includes a magnetic gradient; applying to at least a portion of said animal an electromagnetic perturbation field at a radio frequency generally corresponding to a resonant frequency of a predetermined atomic nucleus at a magnetic field strength which falls within the range of field strengths applied to said animal by said strong magnetic field; and measuring radio frequency emissions given off by magnetically aligned perturbed atomic nuclei, to determine a spatial map or spectral shift of magnetic resonance characteristics within tissues of said animal.
Claim 38
Independent Claim
240 words
A method for enhancing induced internal magnetic resonance images or shifting spectra arising from induced internal magnetic resonance signals, comprising the steps of: identifying a living vertebrate animal to be imaged; introducing into the blood stream or body cavity of said animal a diagnostic imaging or enhancing agent or spectral shift agent comprising a substantially completely water-soluble polymeric carrier molecule of native or modified Fraction A heparin or fragment thereof having a molecular weight range between about 1,000 Daltons and 10,000 Daltons, and having binding complementarity to determinants of mammalian endothelia and epithelia, said agent also comprising a polyatomic complex associated with said carrier molecule, said polyatomic complex including plural atoms of magnetic moment which are mutually magnetically coupled within the polyatomic complex said polyatomic complex essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands, applying to said animal a strong magnetic field which includes a magnetic gradient; applying to at least a portion of said animal an electromagnetic perturbation field at a radio frequency generally corresponding to a resonant frequency of a predetermined atomic nucleus at a magnetic field strength which falls within the range of field strengths applied to said animal by said strong magnetic field; and measuring radio frequency emissions given off by magnetically aligned perturbed atomic nuclei, to determine a spatial map or spectral shift of magnetic resonance characteristics within tissues of said animal.
Claim 39
Dependent Claim
14 words
The composition of claim 1, 5 or 6 defined further as comprising a stabilizer.
Claim 40
Dependent Claim
10 words
The composition of claim 34 wherein the stabilizer is protamine.
Claim 41
Dependent Claim
20 words
The composition of claim 35 wherein the heparin and protamine are in a weight ratio between about 98:2 and 2:98.
Claim 42
Dependent Claim
10 words
The composition of claim 34 wherein the stabilizer is hexadimethrine.
Claim 43
Dependent Claim
21 words
The composition of claim 37 wherein the heparin and hexadimethrine are in a weight ratio of between about 98:2 and 2:98.
Claim 44
Dependent Claim
10 words
The composition of claim 34 wherein the stabilizer is starch.
Claim 45
Dependent Claim
19 words
The composition of claim 39 wherein the weight ratio of heparin to starch is between about 98:2 and 2:98.
References Cited (Backward Citations)
GB1529150A
Cited
US4247406A
Cited
US4370476A
Cited
US4385046A
Cited
US4647447A
Cited
US4963344B1
Cited
US5021236A
Cited
US4963344A
Cited
US4957939A
Cited
US4452773A
Cited
US4472509A
Cited
US4731239A
Cited
GB2137612A
Cited
US4423158A
Cited
US4735796A
Cited
WO1985005554A1
Cited
US4639365A
Cited
EP0186947A1
Cited
US4986980A
Cited
US4985233A
Cited
EP0184899A1
Cited
US4735210A
Cited
US4904479A
Cited
US4770183A
Cited
US4822594A
Cited
US5055288A
Cited
US4832877A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-05-24 | 1996-11-23 | 1997-05-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-05-24 | 2000-11-23 | 2001-05-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-05-24 | 2004-11-23 | 2005-05-25 | $7700.00 | Window Closed / Lapsed |